Literature DB >> 19451035

Multiple sclerosis - a response-to-damage model.

Bert A 't Hart1, Rogier Q Hintzen, Jon D Laman.   

Abstract

According to a widely supported but unproven concept, the autoimmune mechanisms that drive neuroinflammation in multiple sclerosis (MS) are triggered by virus infection. However, a direct viral trigger of MS has not been identified. MS models in non-human primates suggest that lifelong asymptomatic infection with certain herpesviruses (e.g. cytomegalovirus) creates a repertoire of potentially autoreactive memory T cells. When these are exposed to antigens released after central nervous system injury as a consequence of an unknown pathogenic event, they are reactivated and induce autoimmune neurological disease. This response-to-damage of antiviral memory cells can take place years after the initiating infection. Consequently, elucidating the anti-herpesvirus T-cell repertoire might provide new targets for preventive diagnosis and therapy.

Entities:  

Mesh:

Year:  2009        PMID: 19451035     DOI: 10.1016/j.molmed.2009.04.001

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  23 in total

Review 1.  Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).

Authors:  Cris S Constantinescu; Nasr Farooqi; Kate O'Brien; Bruno Gran
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 2.  Viruses and Multiple Sclerosis: From Mechanisms and Pathways to Translational Research Opportunities.

Authors:  Alexios-Fotios A Mentis; Efthimios Dardiotis; Nikolaos Grigoriadis; Efthimia Petinaki; Georgios M Hadjigeorgiou
Journal:  Mol Neurobiol       Date:  2017-04-28       Impact factor: 5.590

3.  Lupus autoimmunity altered by cellular methylation metabolism.

Authors:  Mei-Ling Yang; Alaric J P Gee; Renelle J Gee; Cecilia I Zurita-Lopez; Shilpi Khare; Steven G Clarke; Mark J Mamula
Journal:  Autoimmunity       Date:  2012-11-01       Impact factor: 2.815

4.  Comparative analysis of inflammatory infiltrates in collagen-induced arthritis, kidney graft rejection and delayed-type hypersensitivity in non-human primates.

Authors:  Margreet Jonker; Jacqueline Wubben; Krista Haanstra; Michel Vierboom; Bert 't Hart
Journal:  Inflamm Res       Date:  2012-10-13       Impact factor: 4.575

5.  The different clinical effects of anti-BLyS, anti-APRIL and anti-CD20 antibodies point at a critical pathogenic role of γ-herpesvirus infected B cells in the marmoset EAE model.

Authors:  S Anwar Jagessar; Zahra Fagrouch; Nicole Heijmans; Jan Bauer; Jon D Laman; Luke Oh; Thi Migone; Ernst J Verschoor; Bert A 't Hart
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-19       Impact factor: 4.147

Review 6.  Experimental autoimmune encephalomyelitis in the common marmoset: a translationally relevant model for the cause and course of multiple sclerosis.

Authors:  Bert A 't Hart
Journal:  Primate Biol       Date:  2019-05-10

Review 7.  Commentary on special issue: CNS diseases and the immune system.

Authors:  Bert A 't Hart; Wilfred F den Dunnen
Journal:  J Neuroimmune Pharmacol       Date:  2013-06-12       Impact factor: 4.147

8.  Association between HLA class I and class II alleles and the outcome of West Nile virus infection: an exploratory study.

Authors:  Marion C Lanteri; Zhanna Kaidarova; Trevor Peterson; Steven Cate; Brian Custer; Shiquan Wu; Maria Agapova; Jacqueline P Law; Thomas Bielawny; Frank Plummer; Leslie H Tobler; Mark Loeb; Michael P Busch; Jonathan Bramson; Ma Luo; Philip J Norris
Journal:  PLoS One       Date:  2011-08-01       Impact factor: 3.240

9.  The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis.

Authors:  Bert A 't Hart; S Anwar Jagessar; Krista Haanstra; Ernst Verschoor; Jon D Laman; Yolanda S Kap
Journal:  Front Immunol       Date:  2013-06-13       Impact factor: 7.561

Review 10.  Multiple sclerosis and drug discovery: A work of translation.

Authors:  Bert A 't Hart; Antonio Luchicchi; Geert J Schenk; Joep Killestein; Jeroen J G Geurts
Journal:  EBioMedicine       Date:  2021-05-24       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.